Medical Practice - Rochester, Minnesota, United States
For every 1,000 babies born in the world, between 1-2 have Hydrocephalus. 13% of babies born with Hydrocephalus in the US (and 98% of those born in underdeveloped nations), die within a year of birth.Hydrocephalus or Congenital Hydrocephalus often referred to as "water in the brain", is in fact an excessive accumulation of cerebrospinal fluid. The most common treatment for Hydrocephalus is placement of a shunt in the brain. However, blockage/obstruction caused by metabolic waste, is a frequent problem associated with the Cerebral Shunt in the correction of Congenital Hydrocephalus. As a result, pediatric patients go through several reversal of shunt procedures and repetitive surgeries during their lifetime. This pain and suffering is accompanied with immense physical and emotional trauma, high risks for infections and heavy financial burdens at each such procedure. Our Foundation's goal is to enable cost-effective, clinically efficacious, and durable treatment of Hydrocephalus in children; and to eradicate the lifelong morbidity or mortality associated with non-optimal management of patients.There are 3 clear objectives of the Subramaniam Foundation for Global Brain Health:1. Take the Non-Obstructive Cerebral Shunt design from diagram to prototype; animal trials to clinical trials; and ultimately seek FDA approval.2. Make shunts universally accessible in both, developed and underdeveloped nations.3. Distribute shunts free of charge to all children with Hydrocephalus in under-developed nations.